Answers are grounded in this paper and cite their sources.
Metabolic dysfunction and frailty are interrelated dimensions of cardiometabolic vulnerability. We examined four frailty-integrated lipid-related metabolic indices in relation to incident cardiovascular disease (CVD) and cardiometabolic multimorbidity (CMM) across three longitudinal ageing cohorts and assessed whether they added information beyond their individual components. We analyzed adults aged ≥ 50 years from the China Health and Retirement Longitudinal Study (CHARLS), English Longitudinal Study of Ageing (ELSA), and Health and Retirement Study (HRS). A harmonized cardiometabolic-free frailty index (FI) was combined with the single-point insulin sensitivity estimator, cardiometabolic index, lipid accumulation product, and triglyceride-glucose index to derive iSPISE-FI, CMI-FI, LAP-FI, and TyG-FI. Cohort-specific Cox models and random-effects meta-analysis evaluated incident CVD and CMM. We also examined cumulative exposures, component-versus-integrated models in identical samples, discrete-time and competing-risk sensitivity analyses, and alternative LAP definitions. Secondary CVD prediction analyses compared the four integrated indices in identical participants, using CHARLS for model development and ELSA and HRS for external evaluation. Higher baseline integrated-index levels were generally associated with greater risks of CVD and CMM. For CVD, pooled hazard ratios (HRs) per 1-SD higher iSPISE-FI, CMI-FI, LAP-FI, and TyG-FI were 1.212 (95% CI 1.120–1.310), 1.081 (1.016–1.149), 1.119 (1.053–1.190), and 1.250 (1.095–1.426), respectively. For CMM, the corresponding HRs were 1.271 (1.138–1.420), 1.089 (0.860–1.379), 1.119 (1.047–1.196), and 1.268 (1.136–1.417); CMI-FI showed substantial between-cohort heterogeneity. Models including frailty and the corresponding metabolic component separately generally showed discrimination comparable to or greater than that of the integrated-index models. Prediction models showed modest Harrell C-index increments over P0, with no index consistently superior across cohorts, and external calibration varied, with overprediction in ELSA. Frailty-integrated lipid-related metabolic indices were generally associated with incident CVD and CMM, although associations varied across constructs and populations. Comparative analyses support these integrated indices as concise markers of combined metabolic–frailty vulnerability rather than as measures that consistently improve prediction beyond frailty and metabolic components considered separately. Individual-level risk prediction requires further external evaluation and population-specific calibration.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: